|
US6331299B1
(en)
|
1995-08-18 |
2001-12-18 |
Sloan-Kettering Institute For Cancer Research |
Method for treatment of cancer and infectious disease and compositions useful in same
|
|
US6773707B1
(en)
|
1995-08-18 |
2004-08-10 |
Sloan-Kettering Institute For Cancer Research |
Heat shock protein-based vaccines and immunotherapies
|
|
US6761892B1
(en)
|
1995-08-18 |
2004-07-13 |
Sloan-Kettering Institute For Cancer Research |
Heat shock protein-based vaccines and immunotherapies
|
|
US6719974B1
(en)
|
1995-08-18 |
2004-04-13 |
Sloan-Kettering Institute For Cancer Research |
Heat shock protein-based vaccines and immunotherapies
|
|
IL123218A0
(en)
|
1995-08-18 |
1998-09-24 |
Sloan Kettering Inst Cancer |
Heat shock protein-based vaccines and immunotherapies
|
|
US6017540A
(en)
*
|
1997-02-07 |
2000-01-25 |
Fordham University |
Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress protein-peptide complexes
|
|
AU2005201826B2
(en)
*
|
1997-08-05 |
2008-01-17 |
Nventa Biopharmaceuticals Corporation |
Immune responses against HPV antigens elicited by compositions comprising an HPV antigen and a stress protein or an expression vector capable of expression of these proteins
|
|
NZ538399A
(en)
|
1997-08-05 |
2007-05-31 |
Nventa Biopharma Corp |
Fusion protein comprising an HPV E7 protein and a stress protein wherein the E7 protein is joined directly to the amino terminus of the stress protein
|
|
EP1336621B1
(en)
*
|
1997-08-05 |
2006-05-24 |
Stressgen Biotechnologies Corporation |
Immune responses against HPV antigens elicited by compositions comprising an HPV antigen and a stress protein or an expression vector capable of expression of these proteins
|
|
US5948646A
(en)
*
|
1997-12-11 |
1999-09-07 |
Fordham University |
Methods for preparation of vaccines against cancer comprising heat shock protein-peptide complexes
|
|
WO1999042121A1
(en)
|
1998-02-20 |
1999-08-26 |
University Of Miami |
Modified heat shock protein-antigenic peptide complex
|
|
US6797480B1
(en)
|
1998-10-05 |
2004-09-28 |
University Of Connecticut Health Center |
Purification of heat shock/stress protein cell surface receptors and their use as immunotherapeutic agents
|
|
GB9919733D0
(en)
*
|
1999-08-19 |
1999-10-20 |
Colaco Camilo |
Vaccines against intracellular pathogens
|
|
AUPQ233799A0
(en)
|
1999-08-19 |
1999-09-09 |
Minister For Agriculture, Minister For Land And Water Conservation For And On Behalf Of The State Of New South Wales |
Recombinant sub-unit vaccine
|
|
US7378096B2
(en)
|
1999-09-30 |
2008-05-27 |
Health Research, Inc. |
Stress protein compositions and methods for prevention and treatment of cancer and infectious disease
|
|
AU7743100A
(en)
|
1999-09-30 |
2001-04-30 |
Corixa Corporation |
Stress protein compositions and methods for prevention and treatment of cancer and infectious disease
|
|
US7030228B1
(en)
|
1999-11-15 |
2006-04-18 |
Miltenyi Biotec Gmbh |
Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
|
|
EP1286693A4
(en)
|
2000-06-02 |
2005-07-13 |
Univ Connecticut Health Ct |
COMPLEXES OF ALPHA (2) MACROGLOBULIN AND ANTIGENIC MOLECULES FOR USE IN IMMUNOTHERAPY
|
|
CN1635896A
(zh)
*
|
2001-08-20 |
2005-07-06 |
康涅狄格大学健康中心 |
包含用于治疗癌症及感染性疾病的热休克蛋白或α2－巨球蛋白的组合物制备方法
|
|
EP1551957A4
(en)
|
2001-10-01 |
2007-01-24 |
Univ Duke |
ISOLATED POLYPEPTIDE OF THE GRP94 LIGANDEN BINDING DOMAIN AND NUCLEIC ACID, CRYSTALLINE FORM THEREOF, CODING THEREOF, AND SCRAPPING METHOD WHERE IT IS USED
|
|
WO2003090686A2
(en)
*
|
2002-04-25 |
2003-11-06 |
University Of Connecticut Health Center |
Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
|
|
US7420037B2
(en)
|
2003-02-13 |
2008-09-02 |
Antigenics Inc. |
Heat shock protein-based vaccines and immunotherapies
|
|
WO2004074454A2
(en)
|
2003-02-20 |
2004-09-02 |
University Of Connecticut Health Center |
Methods and compositions for the treatment of cancer and infectious disease using alpha (2) macroglobulin-antigenic molecule complexes
|
|
CN1780850A
(zh)
|
2003-02-28 |
2006-05-31 |
抗基因公司 |
凝集素在促进糖蛋白和抗原分子的低聚反应中的用途
|
|
US7309491B2
(en)
|
2003-04-11 |
2007-12-18 |
Antigenics Inc. |
Heat shock protein-based vaccines and immunotherapies
|
|
CA2538794C
(en)
*
|
2003-09-12 |
2016-04-19 |
Antigenics, Inc. |
Vaccine for treatment and prevention of herpes simplex virus infection
|
|
DK2257301T3
(da)
|
2008-03-03 |
2014-04-28 |
Univ Miami |
Immunterapi baseret på allogene cancerceller.
|
|
JP2011515399A
(ja)
|
2008-03-20 |
2011-05-19 |
ユニバーシティー オブ マイアミ |
熱ショックタンパクｇｐ９６ワクチン接種及びそれを用いた方法
|
|
RU2011144575A
(ru)
|
2009-04-03 |
2013-05-10 |
Эйдженус Инк. |
Способы получения и применения мультишаперон-антигенных комплексов
|
|
GB0910591D0
(en)
*
|
2009-06-19 |
2009-07-29 |
Immunobiology Ltd |
Method for the purification of protein complexes
|
|
GB0916557D0
(en)
|
2009-09-21 |
2009-10-28 |
Health Prot Agency |
Commensal neisserial stress protein complexes
|
|
SG11201705844SA
(en)
|
2015-02-06 |
2017-08-30 |
Heat Biologics Inc |
Vector co-expressing vaccine and costimulatory molecules
|
|
EA201792501A1
(ru)
|
2015-05-13 |
2018-10-31 |
Эйдженус Инк. |
Вакцины для лечения и профилактики рака
|
|
CA3040123A1
(en)
|
2016-10-11 |
2018-04-19 |
University Of Miami |
Vectors and vaccine cells for immunity against zika virus
|
|
CA3058938A1
(en)
|
2017-04-04 |
2018-10-11 |
Heat Biologics, Inc. |
Intratumoral vaccination
|
|
MA52363A
(fr)
|
2018-04-26 |
2021-03-03 |
Agenus Inc |
Compositions peptidiques de liaison à une protéine de choc thermique (hsp) et leurs méthodes d'utilisation
|